BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 12112108)

  • 1. Effects of oxcarbazepine on sodium concentration and water handling.
    Sachdeo RC; Wasserstein A; Mesenbrink PJ; D'Souza J
    Ann Neurol; 2002 May; 51(5):613-20. PubMed ID: 12112108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxcarbazepine-induced hyponatremia and the regulation of serum sodium after replacing carbamazepine with oxcarbazepine in children.
    Holtmann M; Krause M; Opp J; Tokarzewski M; Korn-Merker E; Boenigk HE
    Neuropediatrics; 2002 Dec; 33(6):298-300. PubMed ID: 12571784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of serum sodium after replacing carbamazepine with oxcarbazepine.
    Isojärvi JI; Huuskonen UE; Pakarinen AJ; Vuolteenaho O; Myllylä VV
    Epilepsia; 2001 Jun; 42(6):741-5. PubMed ID: 11422328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatremia from oxcarbazepine and carbamazepine.
    Dong X; Leppik IE; White J; Rarick J
    Neurology; 2005 Dec; 65(12):1976-8. PubMed ID: 16380624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.
    Lin CH; Lu CH; Wang FJ; Tsai MH; Chang WN; Tsai NW; Lai SL; Tseng YL; Chuang YC
    Clin Neuropharmacol; 2010; 33(6):293-6. PubMed ID: 20881597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptomatology of carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
    Berghuis B; Hulst J; Sonsma A; McCormack M; de Haan GJ; Sander JW; Lindhout D; Koeleman BPC
    Epilepsia; 2021 Mar; 62(3):778-784. PubMed ID: 33576502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyponatremia induced by oxcarbazepine.
    Johannessen AC; Nielsen OA
    Epilepsy Res; 1987 Mar; 1(2):155-6. PubMed ID: 3143548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of severe hyponatremia in a patient suffering from epilepsy and using oxcarbazepine].
    Gumbrevicius G; Sveikata A
    Medicina (Kaunas); 2006; 42(8):649-52. PubMed ID: 16963831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes induced by carbamazepine in the action of ADH (antidiuretic hormone) in neurologic patients].
    Vivalda L; Morino U; Nobili M; Carlini M
    Riv Neurol; 1988; 58(3):106-9. PubMed ID: 3175459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, pathophysiology and putative genetic basis of carbamazepine- and oxcarbazepine-induced hyponatremia.
    Berghuis B; de Haan GJ; van den Broek MP; Sander JW; Lindhout D; Koeleman BP
    Eur J Neurol; 2016 Sep; 23(9):1393-9. PubMed ID: 27333872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbamazepine- and oxcarbazepine-induced hyponatremia in people with epilepsy.
    Berghuis B; van der Palen J; de Haan GJ; Lindhout D; Koeleman BPC; Sander JW;
    Epilepsia; 2017 Jul; 58(7):1227-1233. PubMed ID: 28542738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
    Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyponatraemia during oxcarbazepine therapy.
    Pendlebury SC; Moses DK; Eadie MJ
    Hum Toxicol; 1989 Sep; 8(5):337-44. PubMed ID: 2680897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ad hoc change from carbamazepine to oxcarbazepine--effectiveness and tolerance. A retrospective analysis].
    Homberg V; Kowalik A; Schulze-Bonhage A
    Nervenarzt; 2001 Dec; 72(12):918-23. PubMed ID: 11789435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of and risk factors for oxcarbazepine-induced severe and symptomatic hyponatremia.
    Kim YS; Kim DW; Jung KH; Lee ST; Kang BS; Byun JI; Yeom JS; Chu K; Lee SK
    Seizure; 2014 Mar; 23(3):208-12. PubMed ID: 24378204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A vasopressin receptor antagonist (VPA-985) improves serum sodium concentration in patients with hyponatremia: a multicenter, randomized, placebo-controlled trial.
    Wong F; Blei AT; Blendis LM; Thuluvath PJ
    Hepatology; 2003 Jan; 37(1):182-91. PubMed ID: 12500203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In utero oxcarbazepine and a withdrawal syndrome, anomalies, and hyponatremia.
    Rolnitsky A; Merlob P; Klinger G
    Pediatr Neurol; 2013 Jun; 48(6):466-8. PubMed ID: 23668873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyponatremia associated with repeated use of levetiracetam.
    Nasrallah K; Silver B
    Epilepsia; 2005 Jun; 46(6):972-3. PubMed ID: 15946344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia induced by oxcarbazepine in children.
    Borusiak P; Korn-Merker E; Holert N; Boenigk HE
    Epilepsy Res; 1998 May; 30(3):241-6. PubMed ID: 9657651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxcarbazepine-induced hyponatremia, a cross-sectional study.
    Nielsen OA; Johannessen AC; Bardrum B
    Epilepsy Res; 1988; 2(4):269-71. PubMed ID: 3197696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.